Our mission is to provide the Public & Private sector an innovative range of affordable UK manufactured COVID-19 IVD testing solutions that excel in both performance & accuracy. Our focus is to bring new innovations to the in vitro diagnostic industry by implementing new technologies that help the testing processes.
Our aim is to significantly improve on IVD kit components complimented with unique innovative testing technologies to provide a range of testing solutions which can meet the performance needs of our customers. MediPort’s keys focus on a collaborative innovative hub approach in working with biotech firms, medical & IVD specialists along with technology partners, provides a range of IVD product solutions that are unique to the market compared to the traditional standalone product offering.
Passed high standard test at UK laboratories with 0 kit failure rate
MHRA Approved and CE accredited
Meets the World Health Organisation standards for Lateral Flow Testing
This test has a sensitivity accuracy of 96.5%, specificity at 99.7% and overall accuracy 98.6%.
A cost effective solution for rapid testing.
The Mediport LFA will pick up the new variant as it targets the site of the current mutation.
Get a positive or negative result within 15 minutes.
A straightforward test with clear instructions using a QR code and an easy to follow video
Available in large quantities quickly and ready for distribution immediately.
Request a quote or contact us!
If you would like more information about how our testing can help you with your business, you can use the ‘Request a quote’ page, or drop us a message.
MediPort Diagnostics is building a network of distributors around the UK and the world, who are delivering our testing solutions to a new audience.
Contact us today if you are interested in joining our growing distribution network.